Henry Schein Q2 EPS Misses, Stock Falls 9%

Henry Schein reported second-quarter 2025 revenue of $3.24 billion, a 3.2% year-over-year increase that slightly exceeded analyst forecasts. Adjusted earnings per share were $1.10, down from last year and below consensus estimates, while GAAP EPS was 70 cents, also lower than the prior year. Revenue growth in global medical distribution and value-added services was offset by margin pressures, particularly in U.S. dental merchandise due to lower average selling prices and glove pricing. The earnings miss led to a 9% decline in Henry Schein's stock price. The company reaffirmed its 2025 adjusted EPS guidance of $4.80 to $4.94, consistent with analyst expectations. Henry Schein's stock has slightly underperformed the broader market in 2025, with future performance hinging on earnings trends and management's outlook.